FGF4, FGF5, FGF8F, FGF19, and FGF21 significantly enhance survival of human stem cell-derived insulin-secreting beta cells, with FGF4 and FGF5 showing the strongest effects.
- Open access
Moving in bioRxiv, Blood, Cancer Research, Gut and Journal of hepatology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
FGF4, FGF5, FGF8F, FGF19, and FGF21 significantly enhance survival of human stem cell-derived insulin-secreting beta cells, with FGF4 and FGF5 showing the strongest effects.
Targeted therapies for intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements show meaningful response rates and durable disease control.
SEPTIN7 promotes hepatocellular carcinoma progression and therapy resistance by stabilizing FGFR4 and enhancing its recycling, with knockout suppressing tumor development.
SDC1-positive cancer-associated fibroblasts universally promote metastasis across multiple cancers via CTGF secretion and FGFR3 activation, with 554 samples analyzed.
Erythroid-produced intact FGF23 acts as a paracrine inhibitor of erythropoiesis, contributing to anemia in mice models of iron deficiency and chronic kidney disease.
Journals this month
Topics moving, week to 23 Oct 2026